Literature DB >> 2046671

Mutation of serum response factor phosphorylation sites and the mechanism by which its DNA-binding activity is increased by casein kinase II.

J R Manak1, R Prywes.   

Abstract

Casein kinase II (CKII) phosphorylates the mammalian transcription factor serum response factor (SRF) on a serine residue(s) located within a region of the protein spanning amino acids 70 to 92, thereby enhancing its DNA-binding activity in vitro. We report here that serine 83 appears to be the residue phosphorylated by CKII but that three other serines in this region can also be involved in phosphorylation and the enhancement of DNA-binding activity. A mutant that contained glutamate residues in place of these serines had only low-level binding activity; however, when the serines were replaced with glutamates and further mutations were made that increased the negative charge of the region, the resulting mutant showed a constitutively high level of binding equal to that achieved by phosphorylation of wild-type SRF. We have investigated the mechanism by which phosphorylation of SRF increases its DNA-binding activity. We have ruled out the possibilities that phosphorylation affects SRF dimerization or relieves inhibition due to masking of the DNA-binding domain by an amino-terminal region of the protein. Rather, using partial proteolysis to probe SRF's structure, we find that the conformation of SRF's DNA-binding domain is altered by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2046671      PMCID: PMC361119          DOI: 10.1128/mcb.11.7.3652-3659.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Reduced levels of hsp90 compromise steroid receptor action in vivo.

Authors:  D Picard; B Khursheed; M J Garabedian; M G Fortin; S Lindquist; K R Yamamoto
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

2.  Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP.

Authors:  J D Shuman; C R Vinson; S L McKnight
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

3.  A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

Authors:  D Picard; S J Salser; K R Yamamoto
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

4.  Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression.

Authors:  M Z Gilman; R N Wilson; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

5.  Transcriptional regulation of c-fos.

Authors:  R Prywes; T M Fisch; R G Roeder
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1988

6.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

7.  c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore.

Authors:  T M Fisch; R Prywes; R G Roeder
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Casein kinase II enhances the DNA binding activity of serum response factor.

Authors:  J R Manak; N de Bisschop; R M Kris; R Prywes
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

9.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

10.  Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences.

Authors:  M Sheng; S T Dougan; G McFadden; M E Greenberg
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

View more
  28 in total

1.  Protein footprinting at cysteines: probing ATP-modulated contacts in cysteine-substitution mutants of yeast DNA topoisomerase II.

Authors:  B P Tu; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding.

Authors:  J E Lindsley; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

4.  Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation.

Authors:  P W Jurutka; J C Hsieh; S Nakajima; C A Haussler; G K Whitfield; M R Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  ZEMa, a member of a novel group of MADS box genes, is alternatively spliced in maize endosperm.

Authors:  K Montag; F Salamini; R D Thompson
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  cAMP-response element-binding protein (CREB) controls MSK1-mediated phosphorylation of histone H3 at the c-fos promoter in vitro.

Authors:  Miho Shimada; Tomoyoshi Nakadai; Aya Fukuda; Koji Hisatake
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

7.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs.

Authors:  F E Johansen; R Prywes
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties.

Authors:  I M Santoro; K Walsh
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators.

Authors:  R Prywes; H Zhu
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.